文献速递鼻科

长期低剂量多西环素治疗难治性慢性鼻窦炎伴鼻息肉的前瞻性开放标签评估

Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps.
PubMed 文献 · Rhinology · 2017-01-01

这项前瞻性开放标签研究纳入60例接受过内镜鼻窦手术的难治性慢性鼻窦炎伴鼻息肉患者,28例接受鼻用激素、盐水冲洗联合多西环素(首日200 mg,随后100 mg每日一次)治疗12周,30例仅接受鼻用激素和盐水冲洗。多西环素对SNOT-20临床有意义的显著改善显示出足够的效应量,且多西环素组SNOT-20、NOSE和Lund-Kennedy评分结局显著更优。SNOT-20临床显著改善与治疗前存在哮喘、NERD及血清IgE升高呈负相关。

要点

  • 多西环素组SNOT-20、NOSE和Lund-Kennedy评分结局显著优于仅鼻用激素和盐水冲洗组。
  • 多西环素对SNOT-20临床有意义的显著改善显示出足够的效应量。
  • 治疗前哮喘、NERD及血清IgE升高与SNOT-20临床显著改善呈负相关。

核心结论

  • 这些发现提示多西环素可能对CRSwNP患者有益,尤其是治疗前无哮喘、NERD或血清IgE水平不高的患者。

研究设计与样本

  • 前瞻性开放标签研究,纳入60例接受过内镜鼻窦手术的难治性CRSwNP患者,分为多西环素组28例和对照组30例。

主要发现

  • 多西环素对SNOT-20临床有意义的显著改善显示出足够的效应量。
  • 接受多西环素的患者在SNOT-20、NOSE和Lund-Kennedy评分方面结局显著更好。
  • SNOT-20临床显著改善与治疗前存在哮喘、NERD及血清IgE升高呈负相关。

关键数值与推荐

  • 多西环素组:首日200 mg,随后100 mg每日一次,共12周,同时使用鼻用激素和盐水冲洗。
  • 对照组:仅使用鼻用激素和盐水冲洗。
  • 主要结局指标为多西环素治疗对SNOT-20临床有意义的显著改善的足够效应量。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to assess clinical outcomes of long-term low-dose oral doxycycline therapy in difficult-to-treat chronic rhinosinusitis with polyps (CRSwNP). METHODS: This was a prospective, open-label study of 60 patients with difficult-to-treat CRSwNP who had undergone endoscopic sinus surgery. Patients were divided into two groups: 28 received nasal steroids, saline irrigation, and doxycycline (200 mg on the first day, followed by 100 mg once daily) for 12 weeks, while 30 received only nasal steroids and saline irrigation. The main outcome measure was an adequate effect size of doxycycline treatment on clinically meaningful significant improvement of SNOT-20. Other outcome measures were the SNOT-20, NOSE, and Lund-Kennedy scores. The following parameters were also analyzed: asthma, rhinitis, non-steroidal-exacerbated respiratory disease (NERD), and baseline serum IgG, IgA, IgE, IgM, ANCA, and eosinophil count. RESULTS: There was an adequate effect size of doxycycline treatment on clinically meaningful significant improvement of SNOT-20. Patients who received doxycycline also had significantly better outcomes regarding SNOT-20, NOSE, and Lund-Kennedy scores. There was a negative association among a clinically significant improvement of SNOT-20 and presence of asthma, NERD, and elevated serum IgE levels before treatment. CONCLUSION: These findings suggest that doxycycline may have a beneficial role for CRSwNP patients, especially for patients without asthma, NERD or high levels of serum IgE before treatment.

来源:Rhinology,查看原文。版权归原作者所有。

引用

  1. Pinto Bezerra Soter AC, Bezerra TF, Pezato R, et al. Prospective open-label evaluation of long-term low-dose doxycycline for difficult-to-treat chronic rhinosinusitis with nasal polyps. Rhinology. 2017. PMID: 28434014. doi:10.4193/Rhin15.291

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。